In this study, women with ER-/HER2/neu+/Ki67+ DCIS had a greater risk of developing DCIS recurrence than women with other expression profiles (Kerlikowske et al, 2010). The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.